Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does the Human Gut Microbiome Serve as a Novel Personalized Therapeutic Target for Coronary Atherosclerosis?

NCT03009565 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT03009565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03009565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does the Human Gut Microbiome Serve as a Novel Personalized Therapeutic Target for Coronary Atherosclerosis?
Lead sponsor
Rabin Medical Center
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2017
Completion date
January 31, 2019
Enrollment
800 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronary (artery) disease